Dr. Ian Flinn | Contributors


Revlimid and Rituxan Combo 'Another Potential Option' For Patients With Mantle Cell Lymphoma

May 30, 2020

“We now have second and third generation cousins of thalidomide that are very useful. So, lenalidomide in combination with rituximab is an effective therapy for mantle cell lymphoma that voids some of these adverse events that I’m talking about,” said Dr. Ian Flinn. Hear more about this treatment in his interview with CURE®.